Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

Original languageEnglish
JournalMolecular Oncology
ISSN1574-7891
DOIs
Publication statusE-pub ahead of print - 2020

ID: 238743138